Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 9.90
0.00 (0.00%)
Dec 31, 2025, 12:01 PM GMT+1
Creo Medical Group Market Cap
Creo Medical Group has a market cap or net worth of 39.84 million as of December 31, 2025. Its market cap has decreased by -42.56% in one year.
Market Cap
39.84M
Enterprise Value
23.54M
Revenue
4.60M
Ranking
n/a
PE Ratio
44.90
Stock Price
9.90
Market Cap Chart
Since December 9, 2016, Creo Medical Group's market cap has decreased from 64.46M to 39.84M, a decrease of -38.18%. That is a compound annual growth rate of -5.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 39.84M | -49.19% |
| Dec 31, 2024 | 78.42M | -51.05% |
| Dec 29, 2023 | 160.20M | 255.34% |
| Dec 30, 2022 | 45.08M | -83.01% |
| Dec 31, 2021 | 265.37M | -13.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.40B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |